The Living Heart Project of Dassault Systèmes allows virtual experiments on medical devices and even drugs since last year. There are now 130 partners in this project and the collaboration with the FDA could increase this number. The next step for Dassault Systèmes is to plan medical trials with virtual patients. With the demonstration of efficiency of this process, future medical trails could be very different from today and much more accurate. Dassault Systèmes today…"The Living Heart: FDA renews contract with Dassault to evaluate 3D simulation, virtual patients"
Short after a fund raising, Medivis (New York) annonces that SurgicalAR plateform gets now the 510(K) Clearance from FDA. This “Premarket Notification” allows Medivis to deploy this solution across United States territory and increased the number of studies on its effectiveness. Medivis announced that its augmented reality (AR) technology platform for surgical applications, SurgicalAR, has received 510(k) clearance for clinical use in the operating room by the U.S. Food and Drug Administration (FDA). The New…"Medivis SurgicalAR Gets FDA Clearance"